New partnership with Weiss Asset Management Foundation to advance cost-efficiency in malnutrition treatment

Acute malnutrition affects over 40 million children globally. Yet despite the existence of highly effective care, fewer than one in three children receive needed treatment. For this reason, Dioptra is pleased to announce new support from Weiss Asset Management Foundation, which is investing almost US $1 million to help identify and scale cost-efficiency gains in the delivery of malnutrition treatment. 

“The Weiss Asset Management Foundation funds evidence-based, cost-effective, and scalable programs that we believe deliver high risk-adjusted social returns. In a funding-constrained environment, improving cost-efficiency in malnutrition treatment is one of the most direct ways to extend lifesaving care, and Dioptra’s rigorous, real-time approach could help do so at scale. Our partnership comes at an important moment for the sector and reflects a shared commitment to ensuring that limited resources reach as many children as possible.” 

–Leigh Fraiser, Managing Director

The Malnutrition Optimization to Scale Treatment (MOST) program aims to improve the cost-efficiency of member malnutrition programming by 20 percent – a shift that could enable tens of thousands more children to be treated with existing resources. MOST will engage a subset of Dioptra’s membership focused on malnutrition, including  IRC, CARE, Save the Children, Mercy Corps, Catholic Relief Services, and Acción contra el Hambre. 

At a time of growing need and constrained resources, partnerships like this are critical to ensuring humanitarian funding delivers maximum impact.